Literature DB >> 11214096

Cutaneous leishmaniasis in Guatemala: people's knowledge, concepts and practices.

B A Arana1, N R Rizzo, T R Navin, R E Klein, A Kroeger.   

Abstract

Ten rural communities in the northern area of Guatemala where cutaneous leishmaniasis (CL) is endemic were investigated to determine the residents' knowledge of the disease, their related concepts and practices, and their treatment preferences, and to identify the communication channels they use to acquire information. Of 425 heads of household interviewed, 96.7% could accurately describe a typical CL lesion. CL was found to be the fourth most frequently mentioned disease (in studies based on a free list format) and to be considered the sixth most serious (in studies based on paired comparisons). A series of three-way comparisons, used to analyse the subjects' concepts about the similarities of various discases, indicated that CL was considered to be most closely related to skin problems and to be different from any other group of diseases. All interviewees believed that it was necessary to receive treatment for CL, because without treatment the disease would progress, reach the bone, and take years to heal. More than half (55%) of the respondents knew about meglumine antimonate (Glucantime), the most commonly prescribed drug for treating CL in Guatemala. Only a few communication channels that were used by respondents to receive information were identified; the use of radio broadcasts and direct communication via the community leaders appeared to be the most effective.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11214096     DOI: 10.1080/0003490020012416

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  6 in total

1.  Leishmaniasis patients' pilgrimage to access health care in rural Bolivia: a qualitative study using human rights to health approach.

Authors:  Daniel Eid; Miguel San Sebastian; Anna-Karin Hurtig; Isabel Goicolea
Journal:  BMC Int Health Hum Rights       Date:  2019-03-05

2.  Cutaneous leishmaniasis a neglected tropical disease: community knowledge, attitude and practices in an endemic area, Northwest Ethiopia.

Authors:  Helina Fikre Tamiru; Yohana James Mashalla; Rezika Mohammed; Gloria Thupayagale Tshweneagae
Journal:  BMC Infect Dis       Date:  2019-10-16       Impact factor: 3.090

3.  "Cheaper and better": Societal cost savings and budget impact of changing from systemic to intralesional pentavalent antimonials as the first-line treatment for cutaneous leishmaniasis in Bolivia.

Authors:  Daniel Eid Rodríguez; Miguel San Sebastian; Anni-Maria Pulkki-Brännström
Journal:  PLoS Negl Trop Dis       Date:  2019-11-06

4.  Mucocutaneous leishmaniasis: knowledge, attitudes, and practices among paraguayan communities, patients, and health professionals.

Authors:  Mónica Ruoti; Rolando Oddone; Nathalie Lampert; Elizabeth Orué; Michael A Miles; Neal Alexander; Andrea M Rehman; Rebecca Njord; Stephanie Shu; Susannah Brice; Bryony Sinclair; Alison Krentel
Journal:  J Trop Med       Date:  2013-04-15

5.  "The mosquitoes that destroy your face". Social impact of Cutaneous Leishmaniasis in South-eastern Morocco, A qualitative study.

Authors:  Issam Bennis; Loubna Belaid; Vincent De Brouwere; Hind Filali; Hamid Sahibi; Marleen Boelaert
Journal:  PLoS One       Date:  2017-12-20       Impact factor: 3.240

6.  How cutaneous leishmaniasis and treatment impacts in the patients' lives: A cross-sectional study.

Authors:  Endi Lanza Galvão; Mariana Junqueira Pedras; Gláucia Fernandes Cota; Ana Rabello; Taynãna César Simões
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.